Intelligent Bio Solutions Inc.
INBS
Positions held
Your positionsINBS isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $5.21M | Enterprise value | $2.21M | Trailing P/E | — | Forward P/E | 4.49 |
| PEG | — | Price / book | 0.83 | Beta | 4.30 | Dividend yield | 0.00% |
| Revenue growth | 35.8% | Earnings growth | — | Gross margin | 48.6% | Operating margin | -3.5% |
| Profit margin | -2.9% | ROE | -3.1% | ROA | -76.2% | Debt / equity | 0.34 |
| Current ratio | 1.44 | Free cash flow | -$6.72M | Analyst recommendation | none | Mean target | $12.00 |
| 52w high | $24.90 | 52w low | $1.52 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1M | $1.1M | $0.9M | $1.1M | $0.8M | — |
| Op margin | -346.0% | -277.3% | -290.9% | -246.3% | -341.5% | — |
| Net income | -$3.9M | -$2.9M | -$2.7M | -$3.0M | -$3.1M | — |
| Gross margin | 46.8% | 50.5% | 51.3% | 46.6% | 39.8% | — |
| Gross profit | $0.5M | $0.5M | $0.5M | $0.5M | $0.3M | — |
| Operating income | -$4.0M | -$2.9M | -$2.6M | -$2.7M | -$2.9M | — |
- Revenue +8% vs prior quarter ($1.1M vs $1.1M).
- Gross margin 46.8% (was 50.5% prior quarter).
- Operating margin compressed to -346%.
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $4.2M | $3.1M | $3.1M | $1.3M | — |
| Op margin | -292.0% | -342.6% | -330.5% | -671.2% | — |
| Net income | -$12.4M | -$10.6M | -$10.2M | -$10.6M | — |
| Gross margin | 48.6% | 40.8% | 45.8% | 26.0% | — |
| Gross profit | $2.0M | $1.2M | $1.4M | $0.3M | — |
| Operating income | -$12.3M | -$10.5M | -$10.3M | -$8.4M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-10 · Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET
2026-09-09 · Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market
2026-08-17 · Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification
2026-08-05 · Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission
2026-07-21 · Intelligent Bio Solutions Completes Precision Testing of Intelligent Fingerprinting Drug Screening System
Price (daily)
Full chart · RSI · MACD · patterns